Make an Appointment
Talk to DoctorOverview
Porphyria encompasses a collection of rare disorders characterized by an accumulation of natural chemicals called porphyrins, which are essential for producing heme, a component of the hemoglobin protein in red blood cells. Hemoglobin is crucial for transporting oxygen to the body’s organs and tissues. The synthesis of heme requires eight specific enzymes, and a deficiency in any of these enzymes leads to an excessive buildup of porphyrins, causing significant health issues, particularly affecting the nervous system and skin.
There are two primary categories of porphyria: acute and cutaneous. Acute porphyrias manifest rapidly with predominantly neurological symptoms, while cutaneous porphyrias primarily cause skin problems. Some forms of porphyria impact both the nervous system and the skin. Symptoms vary widely depending on the type and severity of the disorder, but they generally include neurological and dermatological manifestations.
Although there is no cure for porphyria, it can often be managed with medication and lifestyle adjustments. Treatment strategies are tailored to the specific type of porphyria, focusing on symptom management. While most types of porphyria are hereditary, passed down from parents to children, one common type, porphyria cutanea tarda (PCT), may not always be inherited.
Symptoms
Systemic mastocytosis and porphyria are two different conditions that present with varying symptoms depending on the affected body parts and the specific type of each condition.
Systemic mastocytosis
Systemic mastocytosis involves an abnormal accumulation of mast cells in various body tissues, including the skin, liver, spleen, bone marrow, and intestines, and occasionally in the brain, heart, or lungs. Symptoms can vary widely:
- Skin: Flushing, itching, hives
- Gastrointestinal: Abdominal pain, diarrhea, nausea, vomiting
- Hematologic: Anemia, bleeding disorders
- Musculoskeletal: Bone and muscle pain
- Organ Enlargement: Liver, spleen, lymph nodes
- Neurological/psychological: Depression, mood changes, concentration problems
Triggers for mast cell activation in systemic mastocytosis commonly include alcohol, skin irritation, spicy foods, exercise, insect stings, and certain medications.
Consult your physician if you experience flushing, hives, or if any of the above symptoms concern you.
Porphyria
Porphyria refers to a group of disorders that can affect the skin or nervous system, with symptoms ranging from mild to severe and potentially life-threatening.
Cutaneous Porphyria: Primarily affects the skin, leading to:
- Oversensitivity to sunlight
- Itching, swelling on sun-exposed skin
- Skin abrasions, blisters, erosions
- Scarring and fragile skin in sun-exposed areas
Acute porphyrias: Affects the nervous system with sudden, short-term symptoms:
- Severe pain in the abdomen, chest, limbs, or back
- Nausea, vomiting, constipation, urinary retention
- Mental changes like confusion and hallucinations
- Seizures, muscle weakness
Symptoms vary by the type of porphyria, and some individuals may be asymptomatic. Urgent medical attention is often required during acute episodes.
Causes
In each type of porphyria, there is a shortage of a specific enzyme crucial for producing heme, an important iron-containing pigment vital for the body’s organs. Heme is a key component of hemoglobin in blood, which carries oxygen and gives red blood cells their color. It is also essential for liver proteins, aiding in liver function.
The production involves eight enzymes in the bone marrow and liver converting porphyrins into heme. Any deficiency or alteration in these enzymes leads to a porphyrin buildup. These compounds accumulate in the liver, skin, and other tissues, potentially leading to symptoms of porphyria.
Each type of porphyria has varying causes, such as:
- Genetic mutations: Porphyria can occur when an individual inherits a modified gene from one parent or from both parents. However, many carriers may never exhibit any signs of the condition. Thus, simply inheriting these altered genes does not necessarily lead to the manifestation of symptoms.
- Acquired forms: Porphyrins can accumulate in response to specific triggers, which may result in symptoms. This is particularly common in porphyria cutanea tarda (PCT). Triggers can include things like:
- Hemochromatosis, a genetic disorder that causes excessive iron in the body
- Hormonal changes during menstruation
- Cigarette consumption
- Excessive alcohol consumption
- Viral illnesses, like hepatitis C or HIV
Risk factors
In most cases, genetic mutations inherited from parents cause porphyria in their offspring. If a parent suffers from porphyria, a child’s risk of developing the condition also increases.
Environmental risk factors can exacerbate porphyria symptoms. Porphyria Cutanea tarda (PCT) is distinct from other forms of porphyrias in that it arises from the reactivation of an inactive acquired disease. The body needs more time to produce hemes when it is exposed to the trigger.
Exposure to the following triggers increases the risk for PCT:
- Alcohol consumption
- Tobacco consumption
- Sunlight exposure
- Hormonal fluctuations
- Some medications, such as barbiturates, sedatives, and birth control tablets
- Stress resulting from emotional or physical conditions including infections, diseases, or surgery
- Illegal or recreational drugs
- Fasting and dieting
- Hemochromatosis
- Chronic hepatitis C
- HIV
Diagnosis
Diagnosing porphyria can be challenging as its symptoms often resemble those of other common diseases, and since it’s a rare condition, it requires specific lab tests for confirmation. If porphyria is suspected, healthcare providers typically conduct a series of tests, including blood, urine, and stool tests, to measure levels of porphyrins and their precursors. These tests help identify the specific type of porphyria. Additionally, genetic testing of a blood sample is utilized for a more precise diagnosis, particularly useful if there is a known family history of the condition. Consulting with a genetic counselor is advised to understand the implications of genetic testing and assess the risk of porphyria for potential offspring and other family members, who may also benefit from testing and counseling.
Treatment
Treatment for porphyria typically involves medications to alleviate symptoms and avoiding triggers such as alcohol. The specific treatment plan is tailored to the type of porphyria and the individual’s symptoms.
- Acute porphyrias: For adults with acute hepatic porphyria, including acute intermittent porphyria, Givosiran, a monthly shot, is available to mitigate the frequency of attacks by targeting liver enzyme deficiencies related to heme production.
In most cases of acute porphyria, treatment medications include administering glucose-containing fluids either intravenously or orally for adequate carbohydrate intake and injections of hemin to reduce porphyrin production. These treatments reduce the quantity of porphyrins or substances that lead to the formation of porphyrins originating from the liver.
Generally, treatment involves swiftly addressing symptoms and averting complications. Some may require hospitalization to manage severe symptoms like pain, vomiting, dehydration, or breathing difficulties.
- Cutaneous porphyrias: For erythropoietic protoporphyria, high doses of beta carotene are often prescribed. Other treatment options include the use of afamelanotide, a medication enhancing melanin production in the skin to shield it from sunlight and extend tolerance to sun exposure without triggering painful skin reactions.
Generally, treatment for cutaneous porphyrias primarily revolves around minimizing exposure to triggers such as sunlight and reducing the levels of porphyrins in the body to alleviate symptoms.
To reduce porphyrin levels, these may be considered:
-
- Undergoing therapeutic phlebotomy, or regular blood draws to decrease iron levels.
- Taking medications like hydroxychloroquine. This may be prescribed in individuals who cannot undergo phlebotomy. This medication aids in absorbing excess porphyrins and expediting their elimination from the body.
- To counteract vitamin D deficiencies resulting from sunlight avoidance, dietary supplements may be recommended.
- Avoiding triggers: To manage porphyria effectively, it is crucial to avoid triggers that could lead to acute attacks. This includes minimizing sun exposure by wearing protective clothing and using sunscreen. At least SPF 30 for brief exposure and SPF 50 for longer durations is recommended. Installing window filters indoors can also help prevent flare-ups.
Other strategies include:
-
- Steer clear of heavy drinking, smoking, and illicit or recreational drug usage
- Discuss premenstrual attack prevention methods with the healthcare provider.
- Steer clear of medications known to cause acute attacks
- Promptly treating infections
- Managing stress
- Avoid fasting, and extreme diets
